Antiphospholipid syndrome and homozygous factor V Leiden mutation in a young patient with Libman-Sacks endocarditis and stroke.
Morissette
Nadesh
N
Gorman
Todd
T
D000293:Adolescent; D000925:Anticoagulants / Q000627:therapeutic use*; D016736:Antiphospholipid Syndrome / Q000150:complications* / Q000188:drug therapy* / Q000235:genetics; D003276:Contraceptives, Oral / Q000008:administration & dosage; D005165:Factor V / Q000235:genetics*; D005260:Female; D006720:Homozygote; D006801:Humans; D007238:Infarction / Q000150:complications / Q000000981:diagnostic imaging*; D019934:International Normalized Ratio; D007668:Kidney / Q000098:blood supply; D008099:Liver / Q000098:blood supply; D008180:Lupus Erythematosus, Systemic / Q000150:complications*; D009154:Mutation; D013154:Spleen / Q000098:blood supply; D020521:Stroke / Q000150:complications / Q000000981:diagnostic imaging*; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
D000925:Anticoagulants; D003276:Contraceptives, Oral; C095381:factor V Leiden; D005165:Factor V